|
|
 |
|
U.K.: Universities venture gives MMI a boost Financial Times Medical Marketing International shares more than doubled to 14 3/8 p yesterday after the technology management group announced a joint venture with two universities to develop a treatment for HIV, the virus that causes AIDS. MMI's anti-viral company, Viratis, will develop the therapy in collaboration with King's College, London, and Queen Mary, University of London.
—Posted: June 10, 2003
More news headlines: This week | Last week | Search archive
|
|
|
